Raúl Sánchez, general manager of Peri Logistics speaks about
In Conversation
of Andrómaco Laboratories. The acquisition has been a major step in Grunenthal’s growth strategy and has almost doubled its revenues in Latin America.
“70 percent of products on the Chilean market cannot demonstrate quality, safety and efficacy through bioequivalence studies”, explains Jean Jacques Duhart,
Rodrigo Azócar Ibaceta, general manager at
Erich Viertel Molina, country manager at Janssen Chile speaks about Janssen’s commitment to the health of Chileans.
Pfizer will invest in a precision medical center studying new genome-based diagnostic technologies for cancer in Chile.
Our business model is new in the Chilean market and enables us with great flexibility and allows us to focus on demand generation. For Ferrer this…
PMG Pharma, a niche player, with
Sebastián Araya van der Schraft, General Manager at Laboratorio Kampar S.A. discusses the new medicine law in Chile—considered a victory by the last government—and further explains…
Last year Pfizer consolidated its position as the world´s largest global pharmaceutical company by acquiring Wyeth, of which you were previously the General Manager here in…
Labomed was bought by Italfarmaco in 2009, but aside from that, what have been the main milestones and achievements of Labomed since its creation in 1968?…
Baxter Chile established itself in the country through the acquisition of a local manufacturer in 1995. What have been the main challenges for the company as…
